Statistics

Total Visits

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results56

Select a period of time:

Number of views in the range

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results28

Views

Views
January 20252
February 20253
March 202512
April 20254
May 20252
June 20253
July 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Singapore11
Brazil1
Canada1
Spain1
United Kingdom1
Turkey1
 

Top cities views

Views
Ankara1
Belo Horizonte1
Buffalo1
Concord1
Council Bluffs1
Redhill1
Regina1